August 12, 2011

Generic drug maker Mylan has begun shipping a drug for enlarged prostate, the company said Friday.

July 18, 2011

Safeway on Monday announced that its month-long prostate cancer campaign raised nearly $10.1 million as part of the company’s ongoing effort to fund research geared toward finding a cure for the leading cancer affecting men.

June 22, 2011

Endo Pharmaceuticals has acquired a provider of devices and therapies for male and female pelvic health.

June 21, 2011

Watson subsidiary Watson Labs is seeking approval for a drug designed to treat symptomatic benign prostatic hyperplasia in men with an enlarged prostate.

June 7, 2011

Safeway once again is raising funds to support prostate cancer research.

June 2, 2011

To celebrate Men's Health Month, Sam's Club is offering free men's health screening tests this weekend at select stores, which will be sponsored by Unilever brands, including Dove Men's deodorant and body wash.

May 18, 2011

A branded drug made by Watson Pharmaceuticals reduced symptoms in men with prostate disease, according to results of a mid-stage clinical trial.

May 18, 2011

A cancer drug made by Amgen reduced the chances of prostate cancer spreading to the bones, according to results of a late-stage clinical trial presented at the American Urological Association’s annual meeting in Washington.

April 29, 2011

The Food and Drug Administration has approved a new treatment for prostate cancer made by Johnson & Johnson.

April 14, 2011

Drug manufacturers are coming up with new versions of their drugs for erectile dysfunction as those drugs’ loss of patent protection and subsequent generic competition draw near, according to published reports.

April 7, 2011

The National Advertising Division of the Council of Better Business Bureaus on Wednesday recommended that DSE Healthcare Solutions, which markets both Cystex urinary pain relief tablets and Cystex liquid cranberry complex with Proantinox, modify its advertising to better distinguish the two products.

March 24, 2011

GlaxoSmithKline withdrew all regulatory approval applications for a drug designed to cut men's risk of developing prostate cancer.

March 3, 2011

Long-term use of a class of drugs used to control pain could increase the risk of erectile dysfunction in men, according to a new study.

November 10, 2010

A specialty pharmacy provider and a manufacturer will collaborate to provide treatments for erectile dysfunction....

October 3, 2010

Safeway kicked off its annual breast cancer awareness initiative for the 10th year in a...

September 30, 2010

Data published in the latest issue of medical journal The Lancet showed that a recently...

September 28, 2010

The Federal Trade Commission has sued the maker of a pomegranate juice that touts health...

September 27, 2010

Pfizer has halted a late-stage trial of a drug therapy in men with prostate cancer,...

August 5, 2010

Drug maker Mission Pharmacal has launched a treatment for urinary tract infections....

July 20, 2010

During what has become a familiar summer tradition that reaches millions of Safeway customers each...

July 14, 2010

Endo Pharmaceuticals has completed its acquisition of a company that provides urological products and services,...

June 30, 2010

Lake Consumer Products on Wednesday announced its purchase of Consumer Choice Systems. The acquisition adds...

June 28, 2010

A recent study being published in the journal Urology found that Proantinox, a proprietary cranberry-based...

June 16, 2010

The Food and Drug Administration has approved a new treatment for advanced prostate cancer, the...